X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (128) 128
humans (118) 118
hiv infections - drug therapy (105) 105
infectious diseases (87) 87
hiv (78) 78
once-daily darunavir/ritonavir (66) 66
pharmacology & pharmacy (63) 63
antiretroviral therapy (56) 56
darunavir (51) 51
female (51) 51
hiv infection (51) 51
safety (51) 51
double-blind (50) 50
efficacy (50) 50
human immunodeficiency virus--hiv (49) 49
male (49) 49
adult (48) 48
antiretroviral drugs (48) 48
protease inhibitors (47) 47
immunology (43) 43
naive hiv-1-infected patients (43) 43
ritonavir (43) 43
drug therapy (42) 42
virology (42) 42
anti-hiv agents - administration & dosage (40) 40
anti-hiv agents - therapeutic use (39) 39
hiv infections - virology (39) 39
hiv-1 - drug effects (39) 39
treatment outcome (39) 39
once-daily dolutegravir (37) 37
highly active antiretroviral therapy (35) 35
hiv-1-infected patients (35) 35
treatment-naive (35) 35
drug therapy, combination (33) 33
twice-daily lopinavir/ritonavir (33) 33
antiviral agents (32) 32
initial treatment (31) 31
middle aged (31) 31
pharmacokinetics (30) 30
ritonavir - administration & dosage (30) 30
treatment-experienced patients (30) 30
viral load (30) 30
cd4 lymphocyte count (27) 27
antiretroviral-naive adults (26) 26
clinical trials (26) 26
hiv-1 (25) 25
raltegravir (25) 25
ritonavir - therapeutic use (25) 25
dolutegravir (24) 24
acquired immune deficiency syndrome--aids (23) 23
antiretroviral agents (23) 23
patients (23) 23
tenofovir (23) 23
active antiretroviral therapy (22) 22
anti-hiv agents - adverse effects (22) 22
hiv protease inhibitors - therapeutic use (22) 22
lopinavir/ritonavir (22) 22
pharmacology (22) 22
combination (21) 21
hiv protease inhibitors - administration & dosage (21) 21
hiv-infected patients (21) 21
microbiology (21) 21
once-daily atazanavir/ritonavir (21) 21
analysis (20) 20
antiretroviral therapy, highly active - methods (20) 20
drug administration schedule (20) 20
emtricitabine (20) 20
health aspects (20) 20
research (20) 20
aids (19) 19
drug interactions (19) 19
efavirenz (19) 19
medicine (19) 19
protease inhibitor (19) 19
sulfonamides - therapeutic use (19) 19
tenofovir disoproxil fumarate (19) 19
therapy (19) 19
aids/hiv (18) 18
care and treatment (18) 18
lopinavir (18) 18
non-inferiority trial (18) 18
proteases (18) 18
co-formulated elvitegravir (17) 17
drug resistance (17) 17
human immunodeficiency virus (17) 17
proteinase inhibitors (17) 17
sulfonamides - administration & dosage (17) 17
atazanavir (16) 16
dosage and administration (16) 16
drug resistance, viral (16) 16
medicine & public health (16) 16
reverse-transcriptase inhibitors (16) 16
young adult (16) 16
hiv integrase inhibitors - therapeutic use (15) 15
hiv-1 infection (15) 15
lamivudine (15) 15
ritonavir - adverse effects (15) 15
complications and side effects (14) 14
drug combinations (14) 14
drug-resistance (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
AIDS, ISSN 0269-9370, 11/2011, Volume 25, Issue 17, pp. 2113 - 2122
Objective: To explore darunavir/ritonavir (DRV/r) plus raltegravir (RAL) combination therapy in antiretroviral-naive patients. Design: Phase IIb, single-arm,... 
INFECTIOUS DISEASES | SAFETY | antiretroviral therapy | nucleoside sparing | raltegravir | INITIAL TREATMENT | IMMUNOLOGY | COMBINATION | VIROLOGY | HIV-1 VIRAL LOAD | ANTIRETROVIRAL DRUG-RESISTANCE | darunavir | LOPINAVIR/RITONAVIR | INFECTION | ONCE-DAILY DARUNAVIR/RITONAVIR | TENOFOVIR
Journal Article
Pediatric infectious disease journal, ISSN 0891-3668, 10/2018, Volume 37, Issue 10, pp. 1008 - 1010
In this multicenter pharmacokinetic study in HIV-infected children (6-12 years of age), we validated the approved once-daily darunavir/ritonavir dosing... 
HIV | children | DRUGS | pharmacokinetics | darunavir | once-daily
Journal Article
AIDS, ISSN 0269-9370, 09/2009, Volume 23, Issue 14, pp. 1829 - 1840
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 05/2013, Volume 85, Issue 5, pp. 755 - 759
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2011, Volume 16, Issue 1, pp. 99 - 108
Background: In the Phase III ARTEMIS Trial, treatment-naive patients received once-daily darunavir/ritonavir (DRV/r) 800/100 mg (n=343) or lopinavir/ritonavir... 
INFECTIOUS DISEASES | HIV-1-INFECTED PATIENTS | ANTIRETROVIRAL THERAPY | DRUG-RESISTANCE | ADHERENCE | HIV-INFECTED PATIENTS | RESPONSES | TREATMENT-NAIVE | VIROLOGY | PHARMACOLOGY & PHARMACY | SOCIETY-USA PANEL | 2008 RECOMMENDATIONS | ONCE-DAILY DARUNAVIR/RITONAVIR
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 05/2016, Volume 10, pp. 1589 - 1603
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 1/2017, Volume 37, Issue 1, pp. 51 - 60
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60814
Journal Article